FindMyKOL

Lynn Hassman, MD

Enriched profile

Associate Professor, Ophthalmology · University of Colorado Anschutz Medical Campus

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Aurora, CO · West · United StatesSpecialtyRetina SpecialistFocusOcular Diseases and Behçet’s Syndrome+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2026

Lynn Hassman is Associate Professor, Ophthalmology at University of Colorado Anschutz Medical Campus. OpenAlex indexes 50 publications with 1,060 citations (h-index 16); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 21 Oct 2026

Overview

Updated 28 Oct 2026

Lynn Hassman, MD, is Associate Professor, Ophthalmology at University of Colorado Anschutz Medical Campus, Department of Ophthalmology (School of Medicine). The public record shows 50 publications with 1,060 citations (h-index 16), centered on Ocular Diseases and Behçet’s Syndrome, Ocular Infections and Treatments, Retinal Diseases and Treatments. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies, 2 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · medRxiv
  • Top research focus: Ocular Diseases and Behçet’s Syndrome
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Dry Eye / Uveitis1 trialUveitis1 trialScleritis1 trialAnkylosing Spondylitis / SpAMacular Degeneration (AMD)

Research focus

OpenAlex concept fingerprint
Ocular Diseases and Behçet’s SyndromeOcular Infections and TreatmentsRetinal Diseases and TreatmentsSpondyloarthritis Studies and TreatmentsOcular Oncology and Treatments

Drugs & molecules

across trials, industry payments and publications
Ozurdexgeneric · DexamethasoneClinical trials—Industry payments2Publications—Xiperegeneric · TriamcinoloneClinical trials—Industry payments2Publications—Gamifantgeneric · EmapalumabClinical trials—Industry payments1Publications—Humirageneric · AdalimumabClinical trials—Industry payments1Publications—Yutiqgeneric · FluocinoloneClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Genentech USA, Inc.Clinical trials—Industry payments14Abbvie Inc.Clinical trials—Industry payments3Bausch & Lomb Americas Inc.Clinical trials—Industry payments2EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments1Sobi, IncClinical trials—Industry payments1Washington University School of MedicineClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
50publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

1,060citations

Total citations across indexed works.

16h-index

Hirsch index (OpenAlex). i10-index 18.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 28 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 28 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

Updated 28 Oct 2026

2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:

Publications

Updated 28 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 28 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Michael Paley13Wayne M. Yokoyama7Jennifer Poursine‐Laurent7Albert T. Vitale6Grace Paley6Philip A. Ruzycki6Alan Gary Palestine5Amit K. Reddy5Ekaterina Esaulova5Nicole Linskey4Lacey Feigl‐Lenzen4Akbar Shakoor4Luke E. Springer4Rajendra S. Apte4Jenny Shunyakova4Marc E. Rothenberg4Julia L. Xia3Christopher D. Conrady3K. Christopher García3Patricia C. Fulkerson3Xinbo Yang3Max Artyomov3Christian Concepcion3Maxim N. Artyomov3Sharon L. Sabapathypillai2Ni Ni Tun2Akshay S. Thomas2Aaditya V. Shah2Robert P. Searles2Kathryn L. Pepple2Zaw Minn Din2Elisha D. O. Roberson2Gregory W. Bligard2Dean H. Kedes2Claire Mitchell2Geraldine M. A. Gillespie2Stephen R. Planck2Dongseok Choi2Ekaterina Loginicheva2Yulia O. Korshunova2

Online presence

Updated 28 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/lynn-hassman-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    medschool.cuanschutz.edu/ophthalmology/about-us/our-team/Hassman-Lynn-UCD6004208339

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.cuanschutz.edu ↗
  • Other

    news.cuanschutz.edu/medicine/university-of-colorado-ophthalmology-researcher-awarded-funding-to-advance-study-of-uveitis-and-ocular-inflammation

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.cuanschutz.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 28 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Virginia School of Medicine

    2012
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗
  • PhD

    University of Virginia, Charlottesville

    2010
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗

Editorial & leadership roles

journal and society appointments
  • Member

    American Academy of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗
  • Member

    American Uveitis Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗
  • Planning Committee Member

    Association of Eye and Vision Research

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗
  • Member

    Federation of Clinical Immunology Societies

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cumedicine.us ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.